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Background/aim: Interleukin 31 (IL31), primarily expressed in activated lymphocytes, signals through a
heterodimeric receptor complex consisting of the IL31 receptor alpha (IL31Ra) and the oncostatin M receptor
(OSMR). The aim of this study was to analyse IL31 receptor expression, signal transduction, and specific
biological functions of this cytokine system in intestinal inflammation.
Methods: Expression studies were performed by RT-PCR, quantitative PCR, western blotting, and
immunohistochemistry. Signal transduction was analysed by western blotting. Cell proliferation was
measured by MTS assays, cell migration by restitution assays.
Results: Colorectal cancer derived intestinal epithelial cell (IEC) lines express both IL31 receptor subunits,
while their expression in unstimulated primary murine IEC was low. LPS and the proinflammatory cytokines
TNF-a, IL1b, IFN-c, and sodium butyrate stimulation increased IL31, IL31Ra, and OSMR mRNA expression,
while IL31 itself enhanced IL8 expression in IEC. IL31 mediates ERK-1/2, Akt, STAT1, and STAT3 activation in
IEC resulting in enhanced IEC migration. However, at low cell density, IL31 had significant antiproliferative
capacities (p,0.005). IL31 mRNA expression was not increased in the TNFDARE mouse model of ileitis but in
inflamed colonic lesions compared to non-inflamed tissue in patients with Crohn’s disease (CD; average 2.4-
fold increase) and in patients with ulcerative colitis (UC; average 2.6-fold increase) and correlated with the IL-
8 expression in these lesions (r = 0.564 for CD; r = 0.650 for UC; total number of biopsies analysed: n = 88).
Conclusion: IEC express the functional IL31 receptor complex. IL31 modulates cell proliferation and migration
suggesting a role in the regulation of intestinal barrier function particularly in intestinal inflammation.
R
ecently, interleukin 31 (IL31) has been identified as a four
helix bundle cytokine that is produced by activated T cells,
particularly by T helper type 2 cells.1 IL31 is closely related
to the IL6-type cytokines oncostatin M (OSM), leukaemia
inhibitory factor (LIF), and cardiotrophin-1 and signals
through a heterodimeric receptor complex composed of the
IL31 receptor alpha (IL31Ra) and the oncostatin M receptor
(OSMR).1 IL31Ra is identical to the gp130-like receptor (GPL).1
At least four splice variants of IL31Ra have been described.1 The
short isoform of IL31Ra exerts a strong inhibitory effect on the
signalling of IL31 and behaves as a dominant negative
receptor.2 The tyrosine residues 652 and 721 in the cytoplasmic
region of the long isoform of IL31Ra/GPL(745) have been
identified as the major STAT5 and STAT3 activating sites,
respectively.3 IL31Ra has sequence and domain homologies
with gp130, LIFR, and granulocyte colony stimulating factor
receptor.1 Expression of IL31Ra and OSMR mRNA has been
shown to be induced in activated monocytes while epithelial
cells express mRNA for both receptors constitutively.1
Activation of the receptor complex resulted in recruitment of
Jak1, Jak2, STAT1, STAT3, STAT5, and PI3 kinase signalling
pathways in glioblastoma and melanoma tumour cells, and
lung epithelial cells.2 4 While IL31 is the only ligand for the
IL31Ra receptor subunit identified so far, the OSMR subunit is
also used by OSM, which signals through a receptor complex
consisting of OSMR and gp130.5
So far, biological functions of this novel cytokine were mainly
analysed in certain skin diseases such as atopic dermatitis.6
Transgenic mice overexpressing IL31 develop a skin disorder
characterised by severe pruritus, alopecia, and skin lesions
suggesting a role for IL31 in skin inflammation.1 A similar
phenotype was induced after subcutaneous delivery of recom-
binant IL31 in mice.1 Peripheral lymph nodes from IL31
transgenic mice and IL31 protein treated mice were enlarged
compared to non-treated and non-transgenic mice.1 In humans,
IL31 was significantly overexpressed in pruritic atopic skin
lesions.7 In vivo, staphylococcal superantigen rapidly induced
IL31 expression in atopic individuals.7 Comparisons between
skin from patients with atopic dermatitis and healthy skin
showed high IL31Ra expression on epidermal keratinocytes and
increased IL31 expression in infiltrating cells in skin samples
taken from atopic patients.8 Moreover, an increased IL31Ra
expression in diseased tissues derived from an animal model of
airway hypersensitivity has been described.1
While the role of IL31 in skin inflammation is well
characterised,1 7–10 its biological properties in other tissues are
largely unknown. Although IL31 expression has been described
in the small intestine and colon,1 the expression of the IL31
Abbreviations: CD, Crohn’s disease; ERK, extracellular signal regulated
kinase; ELISA, enzyme linked immunosorbent assay; FCS, fetal calf serum;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GPL, gp130-like
receptor; IBD, inflammatory bowel disease; IEC, intestinal epithelial cell;
IFN, interferon; IL, interleukin; IL31Ra, interleukin 31 receptor alpha; LIF,
leukaemia inhibitory factor; LIFR, leukaemia inhibitory factor receptor; LPS,
lipopolysaccharide; MAP kinase, mitogen activated protein kinase; MCMV,
murine cytomegalovirus; MEK, mitogen activated protein kinase kinase;
MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium; OSM, oncostatin M; OSMR, oncostatin M
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PCR, reverse transcriptase polymerase chain reaction; SOCS, suppressor of
cytokine signalling; STAT, signal transducer and activator of transcription;
TNF-a, tumour necrosis factor alpha; UC, ulcerative colitis
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receptor complex has not been demonstrated in intestinal
epithelial cells (IEC) so far. Based on the expression of IL31Ra
in epithelial tissues such as skin and lung epithelium and
similarities between skin and gut demonstrated by us for other
STAT inducing cytokines such as IL22,11 we analysed the IL31
receptor expression in the intestinal epithelium and charac-
terised its signal transduction and its specific biological
functions in IEC, particularly in intestinal inflammation.
MATERIALS AND METHODS
Reagents
Polyclonal antibodies to phosphorylated extracellular signal
regulated kinase (ERK) 1/2 (Thr183/Tyr185) and phospho-Akt
(Ser473) were purchased from Cell Signaling (Beverly, MA,
USA). Anti-ERK-1/2 and anti-Akt antibodies were also from
Cell Signaling. Phospho-STAT1 antibody was from BD
Transduction Laboratories (Franklin Lakes, NY, USA), phos-
pho-STAT3 antibody from Upstate Biotechnology (Lake Placid,
NY, USA), and antibodies against STAT1 and STAT3 were from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). Horseradish
peroxidase conjugated secondary antibodies to mouse or rabbit
IgG and chemiluminescent substrate (SuperSignal West Dura
Extended Duration Substrate) were from Pierce (Rockford, IL,
USA). Human IL31Ra antibody was from R&D Systems
(Minneapolis, MN, USA). Recombinant human IL31, tumour
necrosis factor (TNF)-a, IL1b, and interferon (IFN)-c were
obtained from R&D Systems (Minneapolis, MN, USA).
Lipopolysaccharide (LPS) from Escherichia coli (O26:B6) pre-
pared by phenol extraction was purchased from Sigma (St
Louis, MO, USA) and prepared as dispersed sonicate in
endotoxin-free water (Life Technologies, Rockville, MD, USA)
before diluting to final concentration in supplemented media.
Cell culture
The human colorectal cancer derived IEC lines HT-29, SW480,
HCT116, T84, CaCo-2, and DLD-1 were obtained from American
Type Culture Collection (Rockville, MD, USA). Cells were
grown in Dulbecco’s modified Eagle medium (Gibco BRL/Life
Technologies, Gaithersburg, MD, USA) with 100 IU/ml peni-
cillin, 100 mg/ml streptomycin, and 10% heat inactivated fetal
calf serum (PAA, Pasching, Austria) in a humidified 5% CO2
atmosphere at 37 C˚. For signal transduction experiments with
IL31, cells were starved overnight in serum-free medium.
Reverse transcriptase polymerase chain reaction
Reverse transcriptase polymerase chain reaction (RT-PCR) was
performed as previously described.12 Briefly, total RNA was
isolated using Trizol reagent (Gibco BRL/Life Technologies,
Gaithersburg, MD, USA). For RT-PCR, RNA was treated with
ribonuclease (RNase)-free deoxyribonuclease (DNA-free-Kit,
Ambion) to remove potential genomic DNA contaminants. A
volume of 2 mg of total RNA was reverse transcribed using
Qiagen Omniscript RT Kit. To control for genomic contamina-
tion, an identical parallel PCR reaction was performed contain-
ing starting material that had not been reverse transcribed. The
following conditions were used for semi-quantitative PCRs: 40
cycles denaturing at 95 C˚ for 30 seconds, annealing at 60 C˚ for
30 seconds, extension at 72 C˚ for 30 seconds. The primers
(MWG Biotech, Ebersberg, Germany) for the PCR reactions are
shown in table 1. The PCR products were subcloned into pCR
2.1 vector (Invitrogen, Carlsbad, CA, USA) and sequenced.
Quantitative PCR
Real time PCR was performed with an ABI Prism 7700
Sequence Detection System (Applied Biosystems, Darmstadt,
Germany) using the Quantitect SYBR Green PCR Kit from
Qiagen (Hilden, Germany) following the manufacturer’s guide-
lines. Oligonucleotide primers (table 1) were designed accord-
ing to the published sequences. All mRNA expression levels
were normalised to b-actin or GAPDH expression in the
respective cDNA preparation.
Signal transduction experiments, gel electrophoresis,
and immunoblotting
The signal transduction experiments were performed in over-
night serum starved IEC lines as indicated. Cells were
stimulated with 100 ng/ml IL31, unless indicated otherwise.
This concentration was based on pilot experiments demonstrat-
ing a significantly higher effect of 100 ng/ml for the activation
of certain kinases and cell migration than lower concentrations.
Cells were solubilised in lysis buffer containing 1% Nonidet P-
40, 20 mM TRIS-HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA,
2 mM EGTA, 10 mg/ml aprotinin, 2 mM phenylmethylsulfonyl
fluoride, 10 mg/ml leupeptin and phosphatase inhibitors
(400 mM sodium orthovanadate, and 4 mM NaF) and were
passed six times through a 21 gauge needle. After 30 minutes
on ice, lysates were cleared by centrifugation at 10 000 g for
20 minutes. The protein concentration of each sample was
quantified by the Bradford method. Immunoblotting was
performed as previously described.13
Immunofluorescence staining
Immunofluorescence analysis of IL31Ra expression in the IEC
cell line HCT116 was performed as follows. Cells were fixed
with 3.2% paraformaldehyde/PBS for 20 minutes and were
then permeabilised with 0.5% Triton X-100/PBS for 5 minutes.
Cells were blocked with 10% rabbit serum/PBS for 1 hour and
then incubated with the primary antibody (anti-IL31Ra, R&D
Systems) for 1 hour. After washing with PBS, cells were
incubated with a FITC conjugated anti-goat secondary antibody
(Sigma, Taufkirchen, Germany) and Hoechst 33342 (Sigma) for
1 hour. Cells were washed with PBS, mounted with Mowiol
and were analysed under a fluorescence microscope. In
negative controls, cells were stained omitting the primary
antibody.
Enzyme linked immunosorbent assay
For the quantification of IL-8 release, BD OptEIA Human IL-8
ELISA Kit II (BD Biosciences, Bedford, MA, USA) was used
according to the manufacturer’s instructions.
Cell proliferation and cell restitution assays
HCT116 cells were seeded onto 96 well plates at densities of
cells per well as indicated and were allowed to attach overnight.
Table 1 Primers used for PCR analysis
hIL31Ra forward: 59-ggaggggaaaagaatgggta-39
hIL31Ra reverse: 59-cgagggtctcatgctatggt-39
hIL-OSMR forward: 59-ggaatgtgccacacactttg-39
hIL-OSMR reverse: 59-acattggtgccttcttccac-39
hIL31 forward: 59-gaactctgccgtgattcctt-39
hIL31 reverse: 59-aagcctgcagaagaaaagca-39
hIL-8 forward: 59-ccaggaagaaaccaccgga-39
hIL-8 reverse: 59-gaaatcaggaaggctgccaag-39
hb-actin forward: 59-gccaaccgcgagaagatga-39
hb-actin reverse: 59-catcacgatgccagtggta-39
mGAPDH forward: 59-CGTCCCGTAGACAAAATGGT-39
mGAPDH reverse: 59-TCTCCATGGTGGTGAAGACA-39
mIL31R forward: 59-GCGGTGGACACTTGGATAGT-39
mIL31R reverse: 59-ACCCTGGTCTCAGGACCTTT-39
mOSMR forward: 59-ACACCAAGTCCCTTCCACAG-39
mOSMR reverse: 59-ATGGTGACATTGGAGCCTTC-39
mIL31 forward: 59-CAGCTGTTTCAACCCACTG-39
mIL31 reverse: 59-CAGTTCTGCCATGCAGTTTG-39
h: human; m: mouse.
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Cells were then stimulated with 10, 50, and 100 ng/ml IL31, or
with cytokine-free medium (negative control) for 48 hours. The
cell proliferation rate was determined by MTS assay on day 2
using the CellTiter 96 Aqueous Non-Radioactive Cell
Proliferation Assay (Promega, Madison, WI, USA) according
to the manufacturer’s instructions.
Cell restitution assays were performed as wounding assays as
previously described.14 Briefly, SW480 cells, which were the most
suitable IEC line in pilot experiments, were grown in six well
plates to complete confluence. Using a sterile razor blade, eight
standardised wounds were created in each plate. Detached cells
were removed by three washes with PBS, and the cell medium
was changed from 10% FCS containing medium to 0.1% FCS
containing medium. The cells were stimulated with IL31 (100 ng/
ml) or PBS. The cells were washed with PBS after 24 hours and
the number of migrated cells (over the wounding edge) was
counted under a microscope. Five dishes were analysed for each
group (IL31 stimulated and PBS stimulated), whereas for each
dish eight separate fields were counted.
Isolation of primary ileal epithelial cells from
heterozygous TNFDARE mice
Heterozygous TNFDARE mice (a generous gift from Dr G
Kollias; Hellenic Pasteur Institute, Athens, Greece), which
gradually develop chronic inflammation in the ileum from
moderate to severe levels at 8 weeks and 18 weeks of age,15 and
C57BL/6 wild type (WT) mice were killed at the age of
18 weeks. Primary IEC from the ileal and colonic epithelium
of WT and TNFDARE/WT mice were purified as previously
described.16 Briefly, the intestinal tissue was cut into pieces and
incubated at 37 C˚ in DMEM containing 5% FCS and 1 mM
dithiothreitol (DTT) for 30 minutes. The remaining tissue was
incubated in 30 ml PBS containing 1.5 mM EDTA for addi-
tional 10 minutes. The supernatants were filtered, centrifuged
for 5 minutes at 400 g, and the cell pellet was resuspended in
DMEM containing 5% FCS. Finally, the primary IEC suspension
was purified by centrifugation through a 25%/40% discontin-
uous Percoll gradient at 600 g for 30 minutes. Cell purity was
assessed by determining the absence of CD3+ T cell contam-
ination. Trypan blue exclusion confirmed the presence of at
least 80% viable cells after the 2 hour isolation procedure.
Primary IEC from the ileum were collected in sample buffer for
subsequent RNA isolation.
Murine cytomegalovirus infection in vivo
C57BL/6 mice were infected intravenously with 16106 pfu
murine cytomegalovirus (MCMV) of the Smith strain17 in PBS
as previously described.18 Control mice received an injection of
PBS only. After 45 hours, mice were killed by CO2 asphyxiation.
Total RNA of the colon was isolated using Trizol reagent. The
mice in vivo studies were approved by the animal care and use
committee of the State of Bavaria (Regierung von Oberbayern)
following the National Institutes of Health Guide for the Care
and Use of Laboratory Animals.
Figure 1 The IL31 receptor complex and
IL31 are expressed in IEC. (A) mRNA
expression of IL31Ra, OSMR, and IL31 as
analysed by RT-PCR analysis of mRNA
derived from IEC lines as indicated. (B)
Western blot analysis of total cell protein
isolated from HT-29, SW480 and HCT116
cells demonstrates expression of the long,
active isoform of IL31Ra. An amount of
80 mg protein was loaded per lane. (C)
Immunofluorescence staining of HCT116
cells with an IL31Ra specific antibody
demonstrates cell surface expression of
IL31Ra (upper panels) while no specific
staining was obtained with the secondary
antibody only (lower panels).
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Colonic biopsies
Biopsies were taken from patients with CD and UC undergoing
diagnostic colonoscopy. The study was approved by the ethics
committee of the Medical Faculty of the University of Munich.
All participating subjects gave written, informed consent before
biopsy sampling. Four biopsies were collected from each
patient: two from macroscopically non-inflamed sites and two
from macroscopically inflamed mucosa. IL31, IL31Ra, OSMR,
and IL8 mRNA levels were measured in each individual biopsy.
For quantification, the average IL31, IL31Ra, or OSMR and IL8
mRNA expression of the two non-inflamed biopsies was
compared to the average expression in the two inflamed
biopsies. For calculation of the correlation coefficient, IL31
mRNA expression was correlated with the IL8 mRNA expres-
sion in the four individual biopsies for each patient.
Statistical analysis
Statistical analysis was performed using two tailed Student’s t
test. p Values ,0.05 were considered as significant.
RESULTS
The IL31 receptor complex is expressed in IEC lines
Firstly, we determined if the IL31 receptor complex consisting
of IL31Ra and OSMR is expressed in IEC using RT-PCR and
cDNA derived from the human IEC lines HT-29, SW480,
HCT116, T84, CaCo-2, and DLD-1. In addition, we examined
IL31 expression in these cell lines. RT-PCR analysis demonstrated
weak IL31 mRNA expression in all cell lines tested (fig 1A). Using
primers specific for the long isoform of this receptor, IL31Ra
expression was found in all IEC lines analysed with the exception
of T84 and DLD-1 cells (fig 1A). OSMR was expressed in all cell
lines although only at low levels in HT-29 and T84 cells (fig 1A).
The long isoform of IL31Ra was also expressed on protein level in
IEC as demonstrated by western blot (fig 1B) and immunofluor-
escence staining (fig 1C) with an IL31Ra specific antibody. The
strongest expression of both receptor subunits was demonstrated
in SW480 and HCT116 cells (fig 1A and 1B), which we therefore
used in the following signal transduction experiments.
IL31 induces STAT1/3, ERK-1/2, and Akt
phosphorylation
After confirming IL31Ra and OSMR expression in IEC, we next
analysed if this complex is functional in IEC investigating
various signalling pathways after stimulation of HCT116 and
SW480 cells with recombinant IL31. Recent studies in other cell
lines reported activation of STAT and MAP kinase signalling by
IL31,1 4 which we therefore analysed in IEC. These experiments
demonstrated moderate activation of both STAT1 (fig 2A) and
STAT3 (fig 2B) in IEC after stimulation with IL31 (100 ng/ml).
Moreover, IL31 (100 ng/ml) increased phosphorylation levels of
ERK-1/2 (fig 2C) and Akt proteins (fig 2D).
IL31 modulates IEC proliferation and migration
The activation of ERK MAP kinases and Akt has been linked to
increased cell proliferation,11 12 19 20 while a recent study
demonstrated antiproliferative effects for IL31 in lung epithelial
cells mediated via STAT3 activation.21 We therefore analysed
the effect of IL31 on IEC proliferation using MTS assays and the
IEC line HCT116. At cell densities of ,5000 cells/well, IL31
strongly decreased cell proliferation (p = 0.001 for 500 cells/well
stimulated with 50 ng/ml or 100 ng/ml IL31, respectively, vs
medium stimulated cells), while this effect was lost at higher
cell densities and even an opposite, but much less pronounced
proliferation-stimulating effect of IL31 (100 ng/ml) was
observed with 10 000 cells/well and 15 000 cells/well compared
to medium stimulated controls (p = 0.046 and p = 0.013,
respectively; fig 3A).
Recently, we demonstrated that activation of Akt kinases and
STAT proteins is also involved in IEC migration.11 Therefore, we
next analysed the influence of IL31 on IEC migration. As
demonstrated in figure 3B, 100 ng/ml IL31 increased the
migration of HCT116 cells significantly (p = 0.005).
IL31, IL31Ra, and OSMR mRNA expression is
upregulated in an in vitro model of cell differentiation
Given the influence of cell density on the IL31 mediated effects
on cell proliferation, we next analysed potential effects of IEC
differentiation on IL31 and IL31 receptor expression in sodium
butyrate treated IEC, which is an established in vitro model of
cell differentiation.22 23 We measured IL31, IL31Ra, and OSMR
mRNA expression by quantitative PCR in HCT116 cells after
sodium butyrate treatment. There was an increased expression
of all three genes that was most pronounced for IL31Ra mRNA
(270-fold upregulation after 48 hours, fig 3C), while IL31 and
OSMR were upregulated up to 50-fold and 12-fold, respectively
(fig 3C).
IL31, IL31Ra, and OSMR mRNA expression is
upregulated by proinflammatory cytokines and LPS
Given the high expression of IL31 in T cells, which are
consistently found in various forms of intestinal inflammation,
we next characterised expression and potential functions of
IL31 in inflammation. Firstly, we analysed IL31, IL31Ra, and
OSMR mRNA expression in HCT116 cells after stimulation with
Figure 2 IL31 induces STAT1, STAT3, ERK-1/2, and Akt phosphorylation
in IEC. Upon stimulation of HCT116 cells with IL31 (100 ng/ml), (A) STAT1
and (B) STAT3 proteins are phosphorylated. (C) Phospho-ERK-1/2 (p-ERK)
activation after IL31 stimulation (100 ng/ml). (D) IL31 induces Akt
phosphorylation. Similar results were obtained for SW480 cells (data not
shown). One representative experiment (n = 3) is shown.
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LPS and the proinflammatory cytokines TNF-a, IL1b, and IFN-
c. The mRNA expression of all three genes was upregulated
24 hours after stimulation with these proinflammatory cyto-
kines (fig 4). The strongest effect on the transcriptional
regulation of all three IL31 related genes was seen after
stimulation with IFN-c, which increased OSMR expression 5.4-
fold, IL31R mRNA 3.5-fold, and IL31 mRNA 12.1-fold after
24 hours of stimulation.
IL31 increases the expression of proinflammatory
cytokines in IEC
Based on the transcriptional upregulation of IL31 and its
receptor complex by proinflammatory cytokines, we next
analysed if IL31 itself regulates the expression of proinflam-
matory proteins. In this experiment, we studied in the IEC line
HCT116 the effect of IL31 on protein expression of IL8, a
prototypic inflammatory cytokine produced by IEC.24 As shown
in figure 5, IL31 increased IL8 expression 3.1-fold after
24 hours of stimulation.
IL31 mRNA expression does not correlate with TNF-a
mRNA expression in a Th1 mediated model of murine
ileitis
Having shown that IL31, IL31Ra, and OSMR mRNAs are
upregulated under inflammatory conditions in vitro, we next
examined their expression in murine models of intestinal
inflammation in vivo. Using heterozygous TNFDARE mice as a
model of chronic ileitis,15 we demonstrated no significant
differences in IL31 mRNA expression in these mice compared to
wild type mice of the same age and genetic background (fig 6A);
however, there was a trend towards higher IL31 expression in
colonic epithelial cells compared to ileal epithelial cells
(p = 0.088). Similarly, OSMR expression was not significantly
higher in TNFDARE mice in comparison with wild type mice
(fig 6B). In contrast, TNFDARE mice had a significantly higher
TNF-a expression than wild type mice (p,0.01; fig 6C).
IL31 mRNA expression is not upregulated in MCMV
infection in vivo
In another set of experiments, we investigated colonic IL31,
IL31Ra, and OSMR mRNA expression in viral infection using
the murine in vivo model of MCMV infection. C57BL/6 mice
were infected with 106 pfu MCMV of the Smith strain17 as
previously described.18 However, 45 hours after infection, IL31
and IL31Ra mRNA levels were not significantly different
compared to non-infected mice (p = 0.73; fig 6D) while there
was a trend towards a higher OSMR expression in infected mice
(p = 0.06; fig 6D). In contrast, in TNFDARE mice and
corresponding wild type mice, IL31Ra mRNA levels were lower
and just above the detection threshold in both mice strains
without significant differences between the two strains (data
not shown). However, in comparison with the cDNA isolation
of the MCMV infected mice (fig 6D), the isolation procedure of
ileal and colonic epithelial cells of TNFDARE mice yielded much
lower RNA and cDNA amounts, respectively. Using similar
reaction volumes, there was GAPDH detection already after 18
PCR cycles in the MCMV infected mice, while GAPDH was
detected in TNFDARE mice only after 25 PCR cycles, explaining
the different levels of IL31Ra expression in two mouse
experiments.
IL31 mRNA expression is increased in the inflamed
colonic mucosa of patients with inflammatory bowel
disease
We next analysed IL31 and its receptor expression in human
intestinal inflammation in vivo using real time PCR. In this
analysis, we compared IL31, IL31Ra, and OSMR mRNA
expression levels in a total of 88 biopsy samples taken from
22 different patients with inflammatory bowel disease (IBD)
Figure 3 IL31 receptor expression is
modulated by cell differentiation and
influences IEC proliferation and migration.
(A) IL31 influences cell proliferation
depending on cell density as determined by
MTS assay (n = 6 for each cytokine
concentration and cell density; *p,0.05,
**p,0.005). Proliferation in unstimulated
cells was arbitrarily set as 1.0 for each cell
density. Data are presented as mean (SEM).
(B) IL31 stimulation results in significantly
increased cell migration in cell restitution
assays (*p = 0.005). Migration of
unstimulated cells was defined as 1.0. (C)
IL31, IL31Ra, and OSMR mRNA expression
is strongly upregulated during cell
differentiation induced by sodium butyrate.
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including 12 patients with CD and 10 patients with UC. The
biopsies were sampled from sites with endoscopically (macro-
scopic) inflamed colonic mucosa and compared to those of
endoscopically non-inflamed colonic mucosa taken from the
same 22 patients. We used the IL8 mRNA expression in these
biopsies as a control marker of inflammation. IL8 mRNA
expression was significantly increased (p,0.05) in the
inflamed biopsy samples in CD (fig 7A). Moreover, in CD
IL31 mRNA expression levels were higher in inflamed colonic
biopsy samples than in non-inflamed colonic lesions (mean
increase 2.4-fold; fig 7A) and correlated with IL8 mRNA
expression in these patients (r = 0.564; fig 7C). There was also a
twofold higher IL31Ra and OSMR mRNA expression in
inflamed biopsies compared to uninflamed tissue (fig 7A).
Similarly, in eight of the 10 patients with UC the IL31 mRNA
expression was increased in the inflamed lesions (mean
increase 2.6-fold) and correlated with the IL8 mRNA expression
in these lesions (r = 0.650; fig 7B, D). In addition, IL31Ra and
OSMR mRNA expression was slightly increased in the inflamed
tissue of the UC patients (1.5-fold and 1.7-fold, fig 7B).
DISCUSSION
Crohn’s disease and ulcerative colitis, the two main forms of
inflammatory bowel disease, are defined as idiopathic, chronic
relapsing, inflammatory conditions that are immunologically
mediated.25 Despite intensive research their aetiology is only
incompletely understood.25 26 However, several cytokines such
as TNF-a, IL1b, and IL23 play a key part in the aggravation of
intestinal inflammation.25–30 Given its important role in
inflammatory disorders of the skin,1 6–10 we therefore analysed
in this study the novel cytokine IL31 focusing on expression,
signalling, and its role in intestinal inflammation.
While activated T cells are the main source of IL31,1 we here
demonstrate that IEC lines express the functional IL31 receptor
complex consisting of IL31Ra and OSMR, which is consistent
with the expression pattern shown for other epithelial cell types
such as keratinocytes1 and lung epithelial cells.4 After stimula-
tion with IL31, ERK, Akt, and STAT proteins are activated in
IEC. Similar to our findings, activation of STAT1/3 and PI3
kinase signalling has been observed in glioblastoma and
melanoma tumour cells,2 and in lung epithelial cells4 following
IL31 stimulation. However, in agreement with a recent study in
lung epithelial cells, in which strong activation was only
obtained by IL31 receptor overexpression,4 the level of STAT
activation in non-transfected IEC was only moderate.
Recently, we demonstrated that activation of Akt and STAT
proteins mediates IEC proliferation and migration.11 12 19 20
Similarly, our experiments demonstrated that IL31 receptor
activation increases IEC migration. Interestingly, IL31 is located
on chromosome 12q24 in close proximity to chemokine-like
factor 1, which has been very recently shown to be a functional
ligand for CCR4.31 Given the results of our experiments, IL31
also has chemotactic properties influencing the migration of
IEC. Moreover, an influence on cell migration has been
demonstrated for the IL31 related cytokine IL-632 33 and several
other IL6-like cytokines such as LIF.34 In addition, it has been
shown that LIF may upregulate the gene expression of
chemokines such as MCP-1.34 Similarly, we here show that
IL31 increases the expression of the proinflammatory chemo-
kine IL8. Particularly the activation of STAT3 is a common
signalling pathway mediated by these migration stimulating
cytokines.35 For example, we recently demonstrated that
cell migration mediated by the IL-10-like cytokine IL22
is dependent on STAT3 activation.11 A very recent study
Figure 4 IL31Ra, OSMR, and IL31 mRNA expression are upregulated by
proinflammatory stimuli. (A) Regulation of IL31Ra, (B) OSMR, and (C) IL31
by LPS (1 mg/ml) and the proinflammatory cytokines TNF-a (50 ng/ml),
IL1b (10 ng/ml), and IFN-c (1000 U/ml). HCT116 cells were stimulated
for time intervals as indicated and mRNA expression was measured by
quantitative PCR and normalised to b-actin expression.
Figure 5 IL31 increases IL8 expression in IEC. IL8 protein levels increase
and reach a maximum after 24 hours of IL31 stimulation. IL8 protein
concentration was determined by ELISA.
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established that OSMR mediated signal transduction is
negatively regulated by SOCS3 through a receptor tyrosine
independent mechanism.36 Consistently, we demonstrated that
SOCS3 can also inhibit signalling of other STAT activating
cytokines.37–42
IL31Ra belongs to the IL6 cytokine receptor (IL6R) family.
IL6Rs have divergent effects on cell proliferation in different
epithelial cell types. While suppression of proliferation has been
described for IL6R mediated signalling in some epithelial cells,43
it enhances cell growth in other epithelial cell lines.44 45 Here,
we demonstrate that IL31 at high doses and low cell density
significantly decreases cell proliferation in the colorectal cancer
cell line HCT116. Similarly, a very recent study demonstrated
that IL31 was highly effective in suppressing proliferation by
altering expression of cell cycle proteins including upregulation
of p27Kip1 and downregulation of cyclinB1, cdc2, cdk6, mcm4,
and Rb in lung epithelial cells.4 Here, we demonstrate that the
antiproliferative effect of IL31 in HCT116 cells was lost in dense
cell cultures and under certain conditions even reversed into a
proliferation stimulating effect. A similar bimodal effect on cell
Figure 6 IL31 mRNA expression is not
increased in murine models of Th1 mediated
intestinal inflammation. (A) IL31 expression
was similar in ileal and colonic epithelial
cells of TNFDARE mice (n = 9) compared to
C57BL/6 wild type mice (n = 9). Ileal mRNA
expression in wild type mice was arbitrarily
set to 1.0 and all other expression levels
were calculated proportionally as fold
increase. Data are presented as mean
(SEM). (B) OSMR mRNA expression was not
significantly different in TNFDARE mice
compared to wild type mice (p = 0.26). (C)
TNF-a mRNA expression was significantly
higher in TNFDARE mice compared to wild
type mice (p,0.01). (D) IL31, IL31Ra, and
OSMR mRNA expression were not
significantly increased in C57BL/6 mice
infected with murine cytomegalovirus
(n = 10) compared to uninfected C57BL/6
mice (n = 4).
Figure 7 Colonic IL31 mRNA expression is
increased in human inflammatory bowel
disease. (A, C) IL31 expression is increased
2.4-fold in inflamed colonic biopsies from
patients with Crohn’s disease compared to
uninflamed biopsies while IL31Ra and OSMR
expression were increased twofold. IL31
mRNA expression correlated with the IL8
expression (r = 0.56), which was measured
as a marker for inflammation. (B, D) In
patients with ulcerative colitis, a 2.6-fold
increased IL31 mRNA expression was
observed in inflamed biopsies in comparison
with uninflamed tissue with a high correlation
to IL8 mRNA levels (r = 0.65). IL31Ra und
OSMR were increased 1.5-fold and 1.7-fold,
respectively.
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proliferation dependent on cell density has also been described
for other cytokines such as TGF-b.46 However, a number of
studies demonstrated that unstimulated cells in dense cultures
undergoing contact inhibition are characterised by similar
alterations of the expression of cell cycle proteins as caused by
IL31 stimulation4 including downregulation of cyclins47 and
upregulation of p27Kip1,48 which explains the relative loss of
the antiproliferative effect of IL31 (in comparison with
unstimulated cells) in dense cultures considering the overall
low cell proliferation in (unstimulated) dense cultures. Similar
to IL31, other proliferation inhibiting agents such as bone
morphogenetic protein (BMP-7)49 and the MEK inhibitors
PD98059 and U012647 have much higher effects on cell
proliferation inhibition at low cell density compared to dense
cultures. In contrast, cell proliferation stimulating cytokines
such as hepatocyte growth factor (HGF) lose their proliferation
stimulating properties in cell cultures with low cell density.47 It
has been demonstrated that a single STAT3 recruitment site
(Tyr-721) in the cytoplasmic domain of IL31Ra exerts a
dominant function in the entire receptor complex and is critical
for gene induction and growth inhibition.4 Similarly, we
demonstrated upregulation of STAT3 following IL31 stimula-
tion in our study. However, in the initial study,4 an IL31Ra
overexpressing cell line was used explaining the stronger
antiproliferative effects of IL31 observed in that study
compared to our experiments. In addition, it has been
demonstrated that high cell density itself is associated with
ligand independent STAT3 activation mediating growth inhibi-
tion,50 which further explains the loss of the antiproliferative
properties of IL31 in dense cell cultures. Moreover, we
demonstrate that IL31 and IL31 receptor mRNA expression
are cell differentiation dependent, which further supports the
strong influence of cell density on the biological functions of
IL31.
In this study, we demonstrate that proinflammatory cyto-
kines increase the expression of IL31 and its receptor complex.
The strongest upregulation of IL31, IL31Ra, and OSMR gene
expression was seen after stimulation with IFN-c. Similarly, in
monocytes, gene upregulation of IL31Ra was stronger following
IFN-c compared to LPS stimulation.1 Given our quantitative
PCR results of primary murine IEC, which demonstrated in
comparison to colorectal cancer derived IEC only weak IL31Ra
mRNA expression, it is therefore likely that proinflammatory
cytokine activated monocytes are a major IL31Ra expressing
cell type and target of IL31 in IBD.
Depending on the T cell source of cytokine production,
cytokines have been differentiated in Th1 and Th2 cytokines. It
has been proposed that CD represents a Th1 and Th17 mediated
intestinal inflammation, while ulcerative colitis resembles more
a Th2 mediated colitis.30 42 51 IL31 is mainly produced by
activated Th2 cells1 and a very recent study implicates IL31R
signalling as a novel negative regulatory pathway that
specifically limits Th2 mediated inflammation52 while develop-
ment of intestinal pathology in the TNFDARE mouse model
depends on Th1-like cytokines such as IL12 and IFN-c.53 In
contrast, the generation of CD4(+) T cell mediated Th1
responses were normal in IL31Ra(2/2) mice.52 Consistently,
we demonstrated no increased IL31 mRNA expression in
TNFDARE mice, a Th1 mediated murine model of ileitis.15 53
In these mice, baseline colonic IL31 expression was higher than
ileal IL31 expression. This is in agreement with the first report
on IL31 expression in normal tissues demonstrating a higher
IL31 expression in the colon than in the small intestine.1
However, in comparison with uninflamed colonic tissue, the
IL31 mRNA expression was upregulated in inflamed colonic
tissue in both forms of IBD suggesting that in humans IL31
mediated effects are not completely restricted to Th2 mediated
types of inflammation. Moreover, the IL31 mRNA expression
correlated with IL8 mRNA expression in both forms of
intestinal inflammation.
While this is the first report on IL31 in intestinal inflamma-
tion, the role of IL31 in skin inflammation, particularly in
atopic dermatitis is well established.1 7–10 Interestingly, there is
an association between intestinal inflammation and atopic
dermatitis.54 55 Moreover, in patients with atopic dermatitis,
disturbances in intestinal permeability compared to normal
controls have been reported.56 57 Therefore, IL31 producing T
cells may mediate skin reactions as observed in many IBD
patients but this and the role of IL31 on intestinal permeability
need further investigation. Given its effect demonstrated here
on IEC proliferation and migration, it is likely that this novel
cytokine system modulates IEC barrier function. However,
while most colorectal cancer derived IEC expressed consider-
able levels of IL31Ra, its mRNA expression levels in unstimu-
lated murine primary IEC were low suggesting that
cancerogenesis might be another process in which this novel
cytokine is involved. This is supported by IL31Ra expression in
other malignancies such as glioblastoma and melanoma,2
which also secrete a soluble form of OSMR which may bind
IL31 when combined with soluble IL31Ra,58 but further studies
are required to elucidate potential functions of IL31 in
cancerogenesis.
In summary, we demonstrated that IEC express the func-
tional IL31 receptor complex. Binding of IL31 to its surface
receptor complex in IEC leads to phosphorylation of STAT1/3,
Akt, and ERK MAP kinases. IL31 inhibited cell proliferation in
low density cell cultures and increased IEC migration.
Moreover, the mRNA expression of IL31 was upregulated in
inflamed colonic lesions of IBD patients but not in a Th1
mediated model of murine ileitis. Taken together, our data
indicate a role for this cytokine in promoting proinflammatory
gene expression and modulating IEC barrier function suggest-
ing a role in the pathogenesis of IBD.
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